系统性硬化症表达数量性状位点分析识别与疾病病理多方面相关的新候选基因
该研究利用333例系统性硬化症(SSc)患者与524例对照的全血测序数据开展eQTL分析,并与SSc全基因组关联研究(GWAS)数据整合。研究鉴定出49,123个经证实的顺式eQTL,优先筛选出233个候选基因,其中部分与SSc标志性特征相关或在患者血液、皮肤、肺组织中差异表达。结论提示该研究为SSc分子复杂性增添了新层面,有助于更好地理解其发病机制。
要点
- 整合全血eQTL与GWAS数据可优先筛选SSc相关候选基因。
- 233个候选基因中134个与SSc标志性特征相关,105个在血液、皮肤或肺组织中差异表达。
- 10个候选基因可被已批准药物治疗,其中仅3个已在SSc患者中开展临床试验。
核心结论
- 研究提示SSc存在由eQTL介导的分子复杂性新层面,有助于理解疾病发病机制。
研究设计与样本
- 利用333例SSc患者和524例对照的全血测序数据进行eQTL分析,并与SSc GWAS数据整合。
- 整合表达建模、差异表达分析和转录因子结合位点富集结果与SSc关键临床特征。
主要发现
- 从4,539个SSc相关单核苷酸多态性(SNP,PGWAS < 10-5)中检测到49,123个经证实的顺式eQTL。
- 4,539个SSc相关SNP附近1 Mb内有1,436个基因,其中565个基因检测到至少1个与SSc相关SNP的eQTL。
- 按eQTL解释的表达变异(r2 > 0.05)优先筛选出233个候选基因,134个(58%)与SSc标志性特征相关,105个(45%)在患者血液、皮肤或肺组织中差异表达。
- 转录因子结合位点分析显示SSc eQTL中富集24个转录因子(5%)的结合基序,其中ELF1和MGA(血液)、KLF4和ID4(皮肤)、TBX4(肺)在SSc患者中差异调控。
- 10个候选基因(4%)可被已批准用于免疫介导疾病的药物靶向,其中仅3个已在SSc患者中开展临床试验。
关键数值与推荐
- eQTL验证基于4,539个SSc相关SNP(PGWAS < 10-5),基因范围定义为SNP附近1 Mb内。
- 候选基因优先标准为SSc eQTL解释的表达变异r2 > 0.05。
临床怎么用
- 研究结果可为SSc候选基因优先排序及药物靶点评估提供分子依据,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the genetic variants that affect gene expression (expression quantitative trait loci [eQTLs]) in systemic sclerosis (SSc) and to investigate their role in the pathogenesis of the disease. METHODS: We performed an eQTL analysis using whole-blood sequencing data from 333 SSc patients and 524 controls and integrated them with SSc genome-wide association study (GWAS) data. We integrated our findings from expression modeling, differential expression analysis, and transcription factor binding site enrichment with key clinical features of SSc. RESULTS: We detected 49,123 validated cis-eQTLs from 4,539 SSc-associated single-nucleotide polymorphisms (SNPs) (PGWAS < 10-5 ). A total of 1,436 genes were within 1 Mb of the 4,539 SSc-associated SNPs. Of those 1,436 genes, 565 were detected as having ≥1 eQTL with an SSc-associated SNP. We developed a strategy to prioritize disease-associated genes based on their expression variance explained by SSc eQTLs (r2 > 0.05). As a result, 233 candidates were identified, 134 (58%) of them associated with hallmarks of SSc and 105 (45%) of them differentially expressed in the blood cells, skin, or lung tissue of SSc patients. Transcription factor binding site analysis revealed enriched motifs of 24 transcription factors (5%) among SSc eQTLs, 5 of which were found to be differentially regulated in the blood cells (ELF1 and MGA), skin (KLF4 and ID4), and lungs (TBX4) of SSc patients. Ten candidate genes (4%) can be targeted by approved medications for immune-mediated diseases, of which only 3 have been tested in clinical trials in patients with SSc. CONCLUSION: The findings of the present study indicate a new layer to the molecular complexity of SSc, contributing to a better understanding of the pathogenesis of the disease.
引用
- Kerick M, González-Serna D, Carnero-Montoro E, et al. Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology. Arthritis Rheumatol. 2021. PMID: 33455083. doi:10.1002/art.41657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。